p53 mutations in human head and neck cancer cell lines

Acta Oto-Laryngologica, Supplement

Volumn , Issue 529, 1997, Pages 237-240

  Kiuru, Anne ^a   Servomaa, Kristina ^a   Grénman, Reidar ^b   Pulkkinen, Jaakko ^b   Rytömaa, Tapio ^a  

^a STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Alterations; Cell line; P55 tumour suppressor gene; SCCHN

Indexed keywords

PROTEIN P53; DNA;

ALLELE; CANCER CELL CULTURE; CIGARETTE SMOKING; CONFERENCE PAPER; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; LARYNX CARCINOMA; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ARTICLE; CELL CULTURE; DNA SEQUENCE; GENETICS; HEAD AND NECK TUMOR; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED;

EID: 0030611808     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709124132     Document Type: Conference Paper

References (19)

1. Schantz SP, Hsu TC. Head and neck cancer patients express increased clastogen-induced chromosome fragility. Head Neck Surg 1989; 11: 337-43.
2. Choi SY, Kahyo H. Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 1991; 20: 878-85.
3. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993; 72: 1369-75.
4. Harris CC, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993; 329: 1318-27.
5. Brachman DG, Graves D, Yokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992; 62: 4832-6.
6. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52: 5997-6000.
7. Watling DL, Gown AM, Coltrera MD. Overexpression of p53 in head and neck cancer. Head Neck 1992; 14: 437-44.
8. Pavelic ZP, Gluckman JL, Gapany M, et al. Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: Correlation with clinicopathological parameters. Anticancer Res 1992; 12: 1389-94.
9. Chang YS, Lin YJ, Tsai CN, et al. Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polumorphism analysis. Cancer Lett 1992; 67: 167-74.
10. Yin XY, Smith ML, Whiteside TL, et al. Abnormalities in the p53 gene in tumors and cell lines of human squamous cell carcinomas of the head and neck. Int J Cancer 1993; 54: 322-7.
11. Field JK, Spandidos DA, Malliri A, et al. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991; 64: 573-7.
12. Pekkola-Heino K, Kulmala J, Klemi P, et al. Effects of radiation fractination on four squamous cell carcinoma cell lines with dissimilar inherent radiation sensitivity. J Cancer Res Clin Oncol 1991; 117: 597-602.
13. Pekkola-Heino K, Joensuu H, Klemi P, Grénman R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous cell carcinoma cell lines. Arch Otolaryngol Head Neck Surg 1994; 120: 750-4.
14. Servomaa K, Kiuru A, Grénman R., Pekkola-Heino K, Pulkkinen JO, Rytömaa T. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif 1996; 29: 219-30.
15. Pekkola-Heino K, Servomaa K, Kiuru A, Grénman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol (Stockh) 1996; 116: 341-4.
16. Hollstein M, Shomer B, Greenblatt M, et al. Somatic point mutations in the p53 gene of human tumors and cell lines: updated complication. Nucl Acids Res 1996; 24: 141-6.
17. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
18. Ahomadegbe JC, Barrois M, Fogel S, et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995; 10: 1217-27.
19. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 5413-5417.